Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

By Davidkin  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3106-3112

Elsevier

Access to resources Recommend Favorite

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months

By Bottiger M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1759-1762

Elsevier

Access to resources Recommend Favorite

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

By Miller E.   Rush M.   Hill A.   Morgan-Capner P.   Forsey T.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age

By Ceyhan M.   Kanra G.   Erdem G.   Kanra B.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4473-4478

Elsevier

Access to resources Recommend Favorite